The U.S. Department of Defense (DoD) has taken an aggressive stance on cybersecurity transformation: implement Zero Trust ...
Highlights: Robex's Kiniero Gold Project, Guinea, remains on track and budget for first gold pour in Q4 CY25. The Kiniero ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...
Robex’s Kiniero Gold Project, Guinea, remains on track and budget for first gold pour in Q4 CY25. The Kiniero project remains LTI free (lost time injury) with 4,857,704 hours complete to 30 September ...